Research
Thesis
microRNa Regulation of podocyte insulin sensitivity
Publications
2023
2022
2020
2018
2017
2016
- Johnson, F., Phillips, D., Talabani, B., Wonnacott, A., Meran, S. and Phillips, A. 2016. The impact of acute kidney injury in diabetes mellitus. Journal of Thrombosis and Haemostatis 21(6), pp. 506-511. (10.1111/nep.12649)
- Simpson, K., Wonnacott, A., Fraser, D. J. and Bowen, T. 2016. MicroRNAs in diabetic nephropathy: from biomarkers to therapy. Current Diabetes Reports 16(3), article number: 35. (10.1007/s11892-016-0724-8)
2014
- Wonnacott, A., Meran, S., Amphlett, B., Talabani, B. and Phillips, A. 2014. Epidemiology and outcomes in community-acquired versus hospital-acquired AKI. Clinical Journal of the American Society of Nephrology 9(6), pp. 1007-1014. (10.2215/CJN.07920713)
- Meran, S., Wonnacott, A., Amphlett, B. and Phillips, A. 2014. How good are we at managing acute kidney injury in hospital?. Clinical Kidney Journal 7(2), pp. 144-150. (10.1093/ckj/sfu010)
2012
- Wonnacott, A., Meran, S., Roberts, G. W., Donovan, K., Riley, S. G. and Phillips, A. O. 2012. Applying estimated glomerular filtration rate to an ageing population: are we in danger of becoming ageist?. European Journal of Internal Medicine 23(8), pp. 705-710. (10.1016/j.ejim.2012.08.012)
Articles
- Roddick, A. J. et al. 2023. UK Kidney association clinical practice guideline: sodium-glucose co-transporter-2 (SGLT-2) inhibition in adults with kidney disease 2023 UPDATE. BMC Nephrology 24(1), article number: 310. (10.1186/s12882-023-03339-3)
- Wonnacott, A. 2023. The emerging pillars of chronic kidney disease: no longer a bystander in metabolic medicine. Clinical Medicine 23(3), pp. 254-258. (10.7861/clinmed.2023-RM1)
- Wonnacott, A., Denby, L., Coward, R. J. M., Fraser, D. J. and Bowen, T. 2022. MicroRNAs and their delivery in diabetic fibrosis. Advanced Drug Delivery Reviews 182, article number: 114045. (10.1016/j.addr.2021.114045)
- Beltrami, C. et al. 2018. Association of elevated urinary miR-126, miR-155, and miR-29b with diabetic kidney disease. American Journal of Pathology 188(9), pp. 1982-1992. (10.1016/j.ajpath.2018.06.006)
- Wonnacott, A., Bowen, T. and Fraser, D. 2017. MicroRNAs as biomarkers in chronic kidney disease. Current Opinion in Nephrology and Hypertension 26(6), pp. 460-466. (10.1097/MNH.0000000000000356)
- Johnson, F., Phillips, D., Talabani, B., Wonnacott, A., Meran, S. and Phillips, A. 2016. The impact of acute kidney injury in diabetes mellitus. Journal of Thrombosis and Haemostatis 21(6), pp. 506-511. (10.1111/nep.12649)
- Simpson, K., Wonnacott, A., Fraser, D. J. and Bowen, T. 2016. MicroRNAs in diabetic nephropathy: from biomarkers to therapy. Current Diabetes Reports 16(3), article number: 35. (10.1007/s11892-016-0724-8)
- Wonnacott, A., Meran, S., Amphlett, B., Talabani, B. and Phillips, A. 2014. Epidemiology and outcomes in community-acquired versus hospital-acquired AKI. Clinical Journal of the American Society of Nephrology 9(6), pp. 1007-1014. (10.2215/CJN.07920713)
- Meran, S., Wonnacott, A., Amphlett, B. and Phillips, A. 2014. How good are we at managing acute kidney injury in hospital?. Clinical Kidney Journal 7(2), pp. 144-150. (10.1093/ckj/sfu010)
- Wonnacott, A., Meran, S., Roberts, G. W., Donovan, K., Riley, S. G. and Phillips, A. O. 2012. Applying estimated glomerular filtration rate to an ageing population: are we in danger of becoming ageist?. European Journal of Internal Medicine 23(8), pp. 705-710. (10.1016/j.ejim.2012.08.012)
Thesis